After the turmoil of Brexit and the Schrems II decision, a clearer picture is finally emerging around data transfers. We look at how the law stands in light of the newly published EC Standard Contractual Clauses, EDPB Recommendations on Supplementary Measures, and the recently adopted EU-UK adequacy decisions. We also consider how this impacts the life sciences and real estate sectors.